Difficulty: Medium
Average Score: 82%
Practice
Cephalosporin drug that enters to the CNS:
Correct answer
D
Rationale
In the context of ABVD chemotherapy drugs, it is crucial for healthcare professionals to understand the pharmacokinetics of different antibiotics, especially their ability to penetrate the central nervous system (CNS). The correct answer to the question, "Cephalosporin drug that enters the CNS," is D) Ceftriaxone.
Ceftriaxone is a third-generation cephalosporin known for its excellent penetration into the CNS, making it a valuable option for treating central nervous system infections caused by susceptible organisms. Its high lipid solubility and low protein binding allow it to cross the blood-brain barrier effectively.
On the other hand, options A, B, and C (Cefazolin, Cephadroxil, Cephalexin) are not typically associated with significant CNS penetration. These first-generation cephalosporins have limited ability to cross the blood-brain barrier, which restricts their effectiveness in treating CNS infections.
In an educational context, understanding the CNS penetration capabilities of different antibiotics is essential for healthcare professionals when selecting appropriate treatment regimens for patients with CNS infections. This knowledge helps ensure optimal therapeutic outcomes while minimizing the risk of treatment failure or potential adverse effects. Healthcare providers must be able to differentiate between antibiotics based on their pharmacokinetic properties to make informed clinical decisions and provide quality patient care.
Ceftriaxone is a third-generation cephalosporin known for its excellent penetration into the CNS, making it a valuable option for treating central nervous system infections caused by susceptible organisms. Its high lipid solubility and low protein binding allow it to cross the blood-brain barrier effectively.
On the other hand, options A, B, and C (Cefazolin, Cephadroxil, Cephalexin) are not typically associated with significant CNS penetration. These first-generation cephalosporins have limited ability to cross the blood-brain barrier, which restricts their effectiveness in treating CNS infections.
In an educational context, understanding the CNS penetration capabilities of different antibiotics is essential for healthcare professionals when selecting appropriate treatment regimens for patients with CNS infections. This knowledge helps ensure optimal therapeutic outcomes while minimizing the risk of treatment failure or potential adverse effects. Healthcare providers must be able to differentiate between antibiotics based on their pharmacokinetic properties to make informed clinical decisions and provide quality patient care.